Figure 2From: Immunological evaluation of the new stable ultrasound contrast agent LK565: a phase one clinical trial Apical 4 chamber view with LK565 Apical 4 chamber view before (a) and 1 minute after (b) intravenous LK565 application (4 mg/kg BW). Device: SONOS 5500, S3 Probe, harmonicBack to article page